These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 34972732)
1. Extraperitoneal Approach During Peritonectomy in the Right Upper Quadrant for Peritoneal Metastases from Ovarian Malignancies. Acs M; Leebmann H; Häusler S; Harter P; Piso P In Vivo; 2022; 36(1):341-349. PubMed ID: 34972732 [TBL] [Abstract][Full Text] [Related]
2. Total extraperitoneal access for parietal peritonectomy for peritoneal surface malignancy: The 'cocoon' technique. Kyriazanos I; Papageorgiou D; Zoulamoglou M; Marougkas M; Stamos N; Ivros N; Kalles V Eur J Obstet Gynecol Reprod Biol; 2020 Aug; 251():258-262. PubMed ID: 32563137 [TBL] [Abstract][Full Text] [Related]
3. Total parietal peritonectomy with en bloc pelvic resection for advanced ovarian cancer with peritoneal carcinomatosis. Kim HS; Bristow RE; Chang SJ Gynecol Oncol; 2016 Dec; 143(3):688-689. PubMed ID: 27743737 [TBL] [Abstract][Full Text] [Related]
4. Repair of diaphragmatic injury and placement of tube thoracostomy during right upper quadrant peritonectomy. Ozgul N; Basaran D; Boyraz G; Salman MC J Gynecol Oncol; 2016 Jan; 27(1):e6. PubMed ID: 26463433 [TBL] [Abstract][Full Text] [Related]
5. Feasibility and rationale of a novel approach in advanced ovarian cancer surgery: Bat- shaped en-bloc total peritonectomy and total hysterectomy salpingo-oophorectomy with or without rectosigmoid resection (Sarta-Bat approach). Khatib G; Seyfettinoglu S; Guzel AB; Gulec UK; Unlugenc H; Vardar MA Gynecol Oncol; 2021 Apr; 161(1):97-103. PubMed ID: 33234261 [TBL] [Abstract][Full Text] [Related]
6. [Technical essentials and safety analysis of "rolling carpet" cytoreduction surgery in stage Ⅲc epithelial ovarian cancer]. Liu H; Shi Y; Zhang GN; Yu J; Xu SQ; Wang DF; Fan Y; Song SQ; Zhou FZ Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):521-528. PubMed ID: 32854476 [No Abstract] [Full Text] [Related]
7. Diaphragmatic Surgery and Related Complications In Primary Cytoreduction for Advanced Ovarian, Tubal, and Peritoneal Carcinoma. Ye S; He T; Liang S; Chen X; Wu X; Yang H; Xiang L BMC Cancer; 2017 May; 17(1):317. PubMed ID: 28476108 [TBL] [Abstract][Full Text] [Related]
8. The impact of ultra-radical surgery in the management of patients with stage IIIC and IV epithelial ovarian, fallopian tube, and peritoneal cancer. Turnbull HL; Akrivos N; Wemyss-Holden S; Maiya B; Duncan TJ; Nieto JJ; Burbos N Arch Gynecol Obstet; 2017 Mar; 295(3):681-687. PubMed ID: 27995370 [TBL] [Abstract][Full Text] [Related]
9. A novel technique: Carbon dioxide gas-assisted total peritonectomy, diaphragm and intestinal meso stripping in open surgery for advanced ovarian cancer (Çukurova technique). Khatib G; Guzel AB; Gulec UK; Vardar MA Gynecol Oncol; 2017 Sep; 146(3):674-675. PubMed ID: 28720378 [TBL] [Abstract][Full Text] [Related]
10. Diaphragmatic peritonectomy vs. full thickness resection with pleurectomy during Visceral-Peritoneal Debulking (VPD) in 100 consecutive patients with stage IIIC-IV ovarian cancer: A surgical-histological analysis. Soleymani Majd H; Ferrari F; Manek S; Gubbala K; Campanile RG; Hardern K; Tozzi R Gynecol Oncol; 2016 Mar; 140(3):430-5. PubMed ID: 26691220 [TBL] [Abstract][Full Text] [Related]
11. Long-term survival in advanced ovarian carcinoma following cytoreductive surgery with standard peritonectomy procedures. Tentes AA; Mirelis CG; Markakidis SK; Bekiaridou KA; Bougioukas IG; Xanthoulis AI; Tsalkidou EG; Zafiropoulos GH; Nikas IH Int J Gynecol Cancer; 2006; 16(2):490-5. PubMed ID: 16681716 [TBL] [Abstract][Full Text] [Related]
12. Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian carcinoma. Dowdy SC; Loewen RT; Aletti G; Feitoza SS; Cliby W Gynecol Oncol; 2008 May; 109(2):303-7. PubMed ID: 18384866 [TBL] [Abstract][Full Text] [Related]
13. Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center. Muñoz-Casares FC; Medina-Fernández FJ; Arjona-Sánchez Á; Casado-Adam Á; Sánchez-Hidalgo JM; Rubio MJ; Ortega-Salas R; Muñoz-Villanueva MC; Rufián-Peña S; Briceño FJ Eur J Surg Oncol; 2016 Feb; 42(2):224-33. PubMed ID: 26673283 [TBL] [Abstract][Full Text] [Related]
14. Short- and long-term morbidity of total parietal peritonectomy for advanced ovarian cancer. Odajima S; Tanabe H; Koike Y; Onishi J; Ichikawa T; Yokosu K; Takaneka S; Okamoto A Int J Gynecol Cancer; 2023 Nov; 33(11):1771-1777. PubMed ID: 37875321 [TBL] [Abstract][Full Text] [Related]
15. Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer. Eisenhauer EL; D'Angelica MI; Abu-Rustum NR; Sonoda Y; Jarnagin WR; Barakat RR; Chi DS Gynecol Oncol; 2006 Dec; 103(3):871-7. PubMed ID: 16815536 [TBL] [Abstract][Full Text] [Related]
16. Total parietal peritonectomy performed during interval cytoreductive surgery for advanced epithelial serous ovarian cancer results in a low incidence of platinum resistant recurrence- results of a prospective multi-centre study. Bhatt A; Sinukumar S; Parikh L; Mehta S; Shaikh S; Jumle N; Kammar P Eur J Surg Oncol; 2021 Aug; 47(8):2150-2157. PubMed ID: 33875284 [TBL] [Abstract][Full Text] [Related]
18. Primary debulking surgery of the upper abdomen and the diaphragm, with a plasma device surgery system, for advanced ovarian cancer. Cordeiro Vidal G; Babin G; Querleu D; Guyon F Gynecol Oncol; 2017 Jan; 144(1):223-224. PubMed ID: 27836207 [TBL] [Abstract][Full Text] [Related]
19. A collaborative surgical approach to upper and lower abdominal cytoreductive surgery in ovarian cancer. Eng OS; Raoof M; Blakely AM; Yu X; Lee SJ; Han ES; Wakabayashi MT; Yuh B; Lee B; Dellinger TH J Surg Oncol; 2018 Jul; 118(1):121-126. PubMed ID: 29878375 [TBL] [Abstract][Full Text] [Related]
20. Impact of right upper quadrant cytoreductive techniques with extensive liver mobilization on postoperative hepatic function and risk of liver failure in patients with advanced ovarian cancer. Nasser S; Lathouras K; Nixon K; Campbell J; Stocks G; Jiao L; Fotopoulou C Gynecol Oncol; 2018 Dec; 151(3):466-470. PubMed ID: 30278996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]